Publique en esta revista
Información de la revista
Vol. 46. Núm. S7.
Neumología de urgencias
Páginas 1-37 (Octubre 2010)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 46. Núm. S7.
Neumología de urgencias
Páginas 1-37 (Octubre 2010)
DOI: 10.1016/S0300-2896(10)70041-7
Acceso a texto completo
Guía ALERTA 2. América Latina y España: Recomendaciones para la prevención y el Tratamiento de la exacerbación Asmática
Visitas
29801
Gustavo J. Rodrigoa, Vicente Plaza Moralb,??
Autor para correspondencia
vplaza@santpau.cat

Autor para correspondencia.
, Santiago Bardagí Fornsc, José A. Castro-Rodríguezd, Alfredo de Diego Damiáe, Santos Liñán Cortésf, Carlos Melero Morenog, Luis J. Nanninih, Hugo Neffeni, Jorge Salasj
a Departamento de Emergencia, Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay; Departamento de Asma de la Asociación Latinoamericana del Tórax (2006–2008), Montevideo, Uruguay
b Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Área de Asma de la Sociedad Española de Neumología y Cirugía Torácica, Barcelona, España
c Unidad de Neumología, Hospital de Mataró, Sociedad Española de Neumología y Cirugía Torácica, Barcelona, España
d Escuela de Medicina, Pontificia Universidad Católica de Chile, Asociación Latinoamericana del Tórax, Santiago, Chile
e Servicio de Neumología, Hospital Universitario La Fe, Valencia, España, Sociedad Española de Neumología y Cirugía Torácica, Barcelona, España
f Servicio de Neumología Pediátrica, Hospital de Nens de Barcelona, Sociedad Española de Neumología y Cirugía Torácica, Barcelona, España
g Servicio de Neumología, Hospital Universitario 12 de Octubre, Madrid, España, Sociedad Española de Neumología y Cirugía Torácica, Barcelona, España
h Sección de Neumonología, Hospital G. Baigorria, Universidad Nacional de Rosario, Asociación Latinoamericana del Tórax, Santa Fe, Argentina
i Unidad de Medicina Respiratoria, Hospital de Niños O. Alassia, Asociación Latinoamericana del Tórax, Santa Fe, Argentina
j Instituto Nacional de Enfermedades Respiratorias, Departamento de Asma de la Asociación Latinoamericana del Tórax (2008–2010), México DF, México
Este artículo ha recibido
29801
Visitas
Información del artículo
El Texto completo solo está disponible en PDF
Bibliografía
[1.]
G.J. Rodrigo, V. Plaza, J. Bellido-Casado, H. Neffen, M.T. Bazús, G. Levy, et al.
Changes in the characteristics of patients hospitalized for acute asthma over a ten-year period (1994–2004) in Spain and Latin-America: the Eagle study.
Brazilian J Pulmonology, 35 (2009), pp. 635-644
[2.]
G.J. Rodrigo.
¿Están verdaderamente basadas en la evidencia las guías sobre el asma? Un análisis crítico.
Arch Bronconeumol, 44 (2008), pp. 81-86
[3.]
G.J. Rodrigo, C. Rodrigo, J.B. Hall.
Acute asthma in adults. A review.
Chest, 125 (2004), pp. 1081-1102
[4.]
M. Chan-Yeung, J.H. Chang, J. Manfreda, A. Ferguson, A. Becker.
Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma.
Am J Respir Crit Care Med, 156 (1996), pp. 889-893
[5.]
A.E. Tattersfield, D.S. Postma, P.J. Barnes, K. Svensson, C.A. Bauer, P.M. O’Byrne, et al.
Exacerbations of asthma: a descriptive study of 425 severe exacerbations.
Am J Respir Crit Care Med, 160 (1999), pp. 594-599
[6.]
E.M. Martínez-Moragón, A. Perpiñá, A. Belloch, A. De Diego, M.E. Martínez-Francés.
Percepción de la disnea durante la broncoconstricción aguda en los pacientes con asma.
Arch Bronconeumol, 39 (2003), pp. 67-73
[7.]
R. Magadle, N. Berar-Yanay, P. Weiner.
The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea.
Chest, 121 (2002), pp. 329-333
[8.]
M.O. Turner, K. Noertjojo, S. Vedal, T. Bai, S. Crump, J.M. Fitzgerald.
Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma.
Am J Respir Crit Care Med, 157 (1998), pp. 1804-1809
[9.]
V. Plaza, J. Serrano, C. Picado, J. Sanchis.
Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma.
Eur Respir J, 19 (2002), pp. 846-852
[10.]
J.M. Antó, J.M. Sunyer.
Epidemic asthma.
Difficult asthma, pp. 333-340
[11.]
P.G. Woodruff, S.D. Edmond, A.K. Singh, C.A. Camargo.
Sudden-onset acute asthma: clinical features and response to therapy.
Acad Emerg Med, 5 (1998), pp. 695-701
[12.]
G. Rodrigo, C. Rodrigo.
Rapid-onset attack: a prospective study cohort about characteristics and response to emergency department treatment.
Chest, 118 (2000), pp. 1547-1552
[13.]
L. Rubilar, J.A. Castro-Rodríguez, G. Girardi.
Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age.
Pediatr Pulmonol, 29 (2000), pp. 264-269
[14.]
I. Otero González, M. Blanco Aparicio, C. Montero Martínez, P. Valiño López, H. Verea Hernando.
Características epidemiológicas de las exacerbaciones por EPOC y asma en un hospital general.
Arch Bronconeumol, 38 (2002), pp. 256-262
[15.]
S. Gartner, N. Cobos, E. Pérez Yarza, A. Moreno, S. Liñán, C. De Frutos.
Estudio comparativo de la eficacia de deflazacor frente a prednisolona en el tratamiento de la crisis asmática moderada.
An Pediatr (Barc), 61 (2004), pp. 207-212
[16.]
F. Morell, T. Genover, E. Benaque, C. Picado, X. Muñoz, M.J. Cruz.
Incidencia y características de las agudizaciones asmáticas en Barcelona (ASMABII).
Arch Bronconeumol, 45 (2009), pp. 550-555
[17.]
D.M. Mannino, D.M. Homa, L.J. Akinbami, J.E. Moorman, C. Gwynn, S.C. Redd.
Surveillance for asthma. United States, 1980–1999.
MMWR CDC Surveill Summ, 51 (2002), pp. 1-13
[18.]
D.H. Smith, D.C. Malone, K.A. Lawson, L.J. Okamoto, C. Battista, W.B. Saunders.
A national estimate of the economic costs of asthma.
Am J Respir Crit Care Med, 156 (1997), pp. 787-793
[19.]
J. Serra-Batlles, V. Plaza, E. Morejon, A. Comella, J. Brugues.
Costs of asthma according to the degree of severity.
Eur Respir J, 12 (1998), pp. 1322-1326
[20.]
K.B. Weiss, S.D. Sullivan, C.S. Lyttle.
Trends in the cost of illness for asthma in the United States 1985–1994.
J Allergy Clin Immunol, 106 (2000), pp. 493-499
[21.]
L. Borderías Clau, M. Zabaleta Murguionda, J.A. Riesco Miranda, C. Pellicer Ciscar, J.R. Hernandez Hernandez, T. Carrillo Días, et al.
Arch Bronconeumol, 41 (2005), pp. 313-321
[22.]
D. Getahun, K. Demissie, G.G. Rhoads.
Recent trends in asthma hospitalization and mortality in the United States.
J Asthma, 42 (2005), pp. 373-378
[23.]
V. Plaza, J. Serra-Batlles, E. Morejón, A. Comella, J. Brugués.
Características clínicas y morbilidad en el asma estable. Análisis descriptivo del asma en una comunidad mediterránea.
Arch Bronconeumol, 33 (1997), pp. 457-461
[24.]
I. Cerveri, F. Locatelli, M.C. Zoia, A. Corsico, S. Accordini, R. De Marco.
International variations in asthma treatment compliance.
Eur Respir J, 14 (1999), pp. 288-294
[25.]
R. Louis, L.C.K. Lau, A.O. Bron, A.C. Roldaan, M. Radermecker, R. Djukanovic.
The relationship between airways inflammation and asthma severity.
Am J Respir Crit Care Med, 161 (2000), pp. 9-16
[26.]
S. Suissa, P. Ernst.
Inhaled corticosteroids: impact on asthma morbidity and mortality.
J Allergy Clin Immunol, 107 (2001), pp. 937-944
[27.]
I. Mitchell, S.C. Tough, L.K. Semple, F.H. Green, P.A. Hessel.
Near-fatal asthma: a population-based study of risk factors.
Chest, 121 (2002), pp. 1407-1413
[28.]
A.F. Gelb, A. Schein, E. Nussbaum, C.M. Shinar, Y. Aelony, H. Aharonian, et al.
Risk factors for near-fatal asthma.
Chest, 126 (2004), pp. 1138-1146
[29.]
V. Plaza, J. Serra-Batlles, A. Comella, C. Badiola.
Differences in asthma clinical outcomes according to the initial severity.
J Asthma, 42 (2005), pp. 207-211
[30.]
E.M. Skobeloff, W.H. Spivey, S.S. St Clair, J.M. Schoffstall.
The influence of age and sex on asthma admissions.
JAMA, 268 (1992), pp. 3437-3440
[31.]
E. Martínez-Moragón, V. Plaza, J. Serrano, C. Picado, J.B. Gáldiz, A. López-Viña, et al.
Near-fatal asthma related to menstruation.
J Allergy Clin Immunol, 113 (2004), pp. 242-244
[32.]
C.S. Murray, A. Simpson, A. Custovic.
Allergens, viruses and asthma exacerbations.
Proc Am Thorac Soc, 1 (2004), pp. 99-104
[33.]
R.E. Dales, S. Cakmak, S. Judek, T. Dann, F. Coates, J.R. Brook, et al.
Influence of outdoor aeroallergens on hospitalization for asthma in Canada.
J Allergy Clin Immunol, 113 (2004), pp. 303-306
[34.]
S. Hales, S. Lewis, T. Slater, J. Crane, N. Pearce.
Prevalence of asthma symptoms in relation to climate in New Zealand.
Environ Health Perspect, 106 (1998), pp. 607-610
[35.]
N.W. Johnston, M.R. Sears.
Asthma exacerbations. Epidemiology.
Thorax, 61 (2006), pp. 722-728
[36.]
D.R. Taylor, E.D. Bateman, L.P. Boulet, H.A. Boushey, W.W. Busse, T.B. Casale, et al.
A new perspective on concepts of asthma severity and control.
Eur Respir J, 32 (2008), pp. 545-554
[37.]
P.G. Gibson, H. Powell, F.M. Ducharme.
Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
J Allergy Clin Immunol, 119 (2007), pp. 344-350
[38.]
E.F. Juniper, P.M. O’Byrne, P.J. Ferrie, D.R. King, J.N. Roberts.
Measuring asthma control. Clinic questionnaire or daily diary?.
Am J Respir Crit Care Med, 162 (2000), pp. 1330-1334
[39.]
E.F. Juniper, P.M. O’Byrne, G.H. Guyatt, P.J. Ferrie, D.R. King.
Development and validation of a questionnaire to measure asthma control.
Eur Respir J, 14 (1999), pp. 902-907
[40.]
E.F. Juniper, K. Sevensson, A.C. Mörk, E. Stähl.
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire.
Respir Med, 99 (2005), pp. 553-558
[41.]
R.A. Nathan, C.A. Sorkness, M. Kosinski, M. Schatz, J.T. Lim, P. Marcus, et al.
Development of the asthma control test: a survey for assessing asthma control.
J Allergy Clin Immunol, 113 (2004), pp. 59-65
[42.]
M. Schatz, C.A. Sorkness, J.T. Li, P. Marcus, J.J. Murray, R.A. Nathan, et al.
Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists.
J Allergy Clin Immunol, 117 (2006), pp. 549-556
[43.]
J.M. Vega, X. Badia, C. Badiola, A. López-Vinia, J.M. Olaguibel, C. Picado, et al.
Validation of the Spanish version of the Asthma Control Test (ACT).
J Asthma, 44 (2007), pp. 867-872
[44.]
G.J. Rodrigo, J.P. Arcos, L.J. Nannini, H. Neffen, M. González Broin, M. Contrera, et al.
Reliability and factor analysis of the Spanish version of the Asthma Control Test.
Ann Allergy Asthma Immunol, 100 (2008), pp. 17-22
[45.]
P.P. Katz, E.H. Yelin, M.D. Eisner, P.D. Blanc.
Perceived control of asthma and quality of life among adults with asthma.
Ann Allergy Asthma Immunol, 89 (2002), pp. 251-258
[46.]
C.S. Calfee, P.P. Katz, E.H. Yelin, C. Iribarren, M.D. Eisner.
The influence of perceived control of asthma on health outcomes.
Chest, 130 (2006), pp. 1312-1318
[47.]
L. Laforest, E. Van Ganse, G. Devouassoux, L.M. Osman, K. Brice, J. Massol, et al.
Asthmatic patients’ poor awareness of inadequate disease control: a pharmacy-based survey.
Ann Allergy Asthma Immunol, 98 (2007), pp. 146-152
[48.]
P.L. Brand, E.J. Duiverman, H.J. Waalkens, E.E. Van Essen-Zandvliet, K.F. Kerrebijn.
Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long term treatment with inhaled corticosteroids.
Thorax, 54 (1999), pp. 103-107
[49.]
H.K. Reddel, G.B. Marks, C.R. Jenkins.
When can personal best peak flow be determined for asthma action plans?.
Thorax, 59 (2004), pp. 922-924
[50.]
K.J. Killian, R. Watson, J. Otis, T.A. St Amand, P.M. O’Byrne.
Symptom perception during acute bronchoconstriction.
Am J Respir Crit Care Med, 162 (2000), pp. 490-496
[51.]
J.K. Sont, L.N. Willems, E.H. Bel, J.H. Van Krieken, J.P. Vandenbroucke, P.J. Sterk.
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment.
Am J Respir Crit Care Med, 159 (1999), pp. 1043-1051
[52.]
M.M. Pizzichini, T.A. Popov, A. Efthimiadis, P. Hussack, S. Evans, E. Pizzichini, et al.
Spontaneous and induced sputum to measure indices of airway inflammation in asthma.
Am J Respir Crit Care Med, 154 (1996), pp. 866-869
[53.]
R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, P. Brading, et al.
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
Lancet, 360 (2002), pp. 1715-1721
[54.]
A. Jatakanon, S. Kharitonov, S. Lim, P.J. Barnes.
Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma.
Thorax, 54 (1999), pp. 108-114
[55.]
P.E. Silkoff, P. McClean, M. Spino, L. Erlich, A.S. Slutsky, N. Zamel.
Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients.
Chest, 119 (2001), pp. 1322-1328
[56.]
A.D. Smith, J.O. Cowan, K.P. Brassett, G.P. Herbison, D.R. Taylor.
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.
N Engl J Med, 352 (2005), pp. 2163-2173
[57.]
S.I. Jones, J. Kittelson, J.O. Cowan, E.M. Flannery, R.J. Hancox, C.R. McLachlan, et al.
The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control.
Am J Respir Crit Care Med, 164 (2001), pp. 738-743
[58.]
J.M. Sippel, W.E. Holden, S.A. Tilles, M. O’Hollaren, J. Cook, N. Thukkani, et al.
Exhaled nitric oxide levels correlate with measures of disease control in asthma.
J Allergy Clin Immunol, 106 (2000), pp. 645-650
[59.]
A.F. Gelb, C.F. Taylor, C.M. Shinar, C. Gutiérrez, N. Zamel.
Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics.
Chest, 129 (2006), pp. 1492-1499
[60.]
E. Paraskakis, C. Brindicci, L. Fleming, R. Krol, S.A. Kharitonov, N.M. Wilson, et al.
Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma.
Am J Respir Crit Care Med, 174 (2006), pp. 260-267
[61.]
H.L. Petsky, C.J. Cates, A.M. Li, J.A. Kynaston, C. Turner, A.B. Chang.
Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
Cochrane Database Syst Rev, (2008),
[62.]
A.D. Smith, J.O. Cowan, S. Filsell, C. McLachlan, G. Monti-Sheehan, P. Jackson, et al.
Diagnosing asthma. Comparisons between exhaled nitric oxide measurements and conventional tests.
Am J Respir Crit Care Med, 169 (2004), pp. 473-478
[63.]
S.A. Kharitonov, P.J. Barnes.
Exhaled markers of pulmonary disease.
Am J Respir Crit Care Med, 163 (2001), pp. 1693-1722
[64.]
L.P. Boulet, V. Boulet, J. Milot.
How should we quantify asthma control? A proposal.
Chest, 122 (2002), pp. 2217-2223
[65.]
J.M. FitzGerald, P.G. Gibson.
Asthma exacerbations. 4: Prevention.
Thorax, 61 (2006), pp. 992-999
[66.]
R.A. Pauwels, S. Pedersen, W.W. Busse, W.C. Tan, Y.Z. Chen, S.V. Ohlsson, et al.
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.
Lancet, 361 (2003), pp. 1071-1076
[67.]
A. Woolcock, B. Lundback, N. Ringdal, L.A. Jacques.
Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
Am J Respir Crit Care Med, 153 (1996), pp. 1481-1488
[68.]
R.A. Pauwels, C.G. Lofdahl, D.S. Postma, A.E. Tattersfield, P. O’Byrne, P.J. Barnes, et al.
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol And Corticosteroids Establishing Therapy (FACET) International Study Group.
N Engl J Med, 337 (1997), pp. 1405-1411
[69.]
E.D. Bateman, H.A. Boushey, J. Bousquet, W.W. Busse, T.J. Clark, R.A. Pauwels, et al.
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control Study.
Am J Respir Crit Care Med, 170 (2004), pp. 836-844
[70.]
M. Masoli, M. Weatherall, S. Holt, R. Beasley.
Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.
Thorax, 60 (2005), pp. 730-734
[71.]
S.W. Stoloff, D.A. Stempel, J. Meyer, R.H. Stanford, J.R. Carranza Rosenzweig.
Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
J Allergy Clin Immunol, 113 (2004), pp. 245-251
[72.]
P.M. O’Byrne, E. Adelroth.
Beta2 déjà vu.
[73.]
M.J. Vaquerizo, P. Casan, J. Castillo, M. Perpiñá, J. Sanchis, V. Sobradillo, et al.
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.
Thorax, 58 (2003), pp. 204-210
[74.]
H. Milgrom, R.B. Fick, J.Q. Su, J.D. Reimann, R.K. Bush, M.L. Watrous, et al.
Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.
N Engl J Med, 341 (1999), pp. 1966-1973
[75.]
M. Soler, J. Matz, R. Townley, R. Buhl, J. O’Brien, H. Fox, et al.
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.
Eur Respir J, 18 (2001), pp. 254-261
[76.]
H.A. Boushey, C.A. Sorkness, T.S. King, S.D. Sullivan, J.V. Fahy, S.C. Lazarus, et al.
Daily versus as-needed corticosteroids for mild persistent asthma.
N Engl J Med, 352 (2005), pp. 1519-1528
[77.]
A. Papi, G.W. Canonica, P. Maestrelli, P. Paggiaro, D. Olivieri, E. Pozzi, et al.
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.
N Engl J Med, 356 (2007), pp. 2040-2052
[78.]
P.M. O’Byrne, H. Bisgaard, P.P. Godard, M. Pistolesi, M. Palmqvist, Y. Zhu, et al.
Budesonide/formoterol combination as both maintenance and reliever medication in asthma.
Am J Respir Crit Care Med, 171 (2005), pp. 129-136
[79.]
C. Vogelmeier, A. D’Urzo, R. Pauwels, J.M. Merino, M. Jaspal, S. Boutet, et al.
Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?.
Eur Respir J, 26 (2005), pp. 819-828
[80.]
K.F. Rabe, T. Atienza, P. Magyar, P. Larsson, C. Jorup, U. Lalloo.
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
[81.]
L. Jayaram, M.M. Pizzichini, R.J. Cook, L.P. Boulet, C. Lemière, E. Pizzichini, et al.
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations.
Eur Respir J, 27 (2006), pp. 483-494
[82.]
C.G. Lofdahl, T.F. Reiss, J.A. Leff, E. Israel, M.J. Noonan, A.F. Finn, et al.
Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients.
BMJ, 319 (1999), pp. 87-90
[83.]
A. Deykin, M.E. Wechsler, H.A. Boushey, V.M. Chinchilli, S.J. Kunselman, T.J. Craig, et al.
Combination therapy with a long-acting b-agonist and a leukotriene antagonist in moderate asthma.
Am J Respir Crit Care Med, 175 (2007), pp. 228-234
[84.]
L. Bjermer, H. Bisgaard, J. Bousquet, L.M. Fabbri, A.P. Greening, T. Haahtela, et al.
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
[85.]
M.J. Abramson, R.M. Puy, J.M. Weiner.
Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials.
Am J Respir Crit Care Med, 151 (1995), pp. 969-974
[86.]
O. Abadoglu, D. Mungan, G. Pasaoglu, G. Celik, Z. Misirligil.
Influenza vaccination in patients with asthma: effect on the frequency of upper respiratory tract infections and exacerbations.
J Asthma, 41 (2004), pp. 279-283
[87.]
C. Christy, C.A. Aligne, P. Auinger, T. Pulcino, M. Weitzman.
Effectiveness of influenza vaccine for the prevention of asthma exacerbations.
Arch Dis Child, 89 (2004), pp. 734-735
[88.]
A. Sheikh, A. Alves, S. Dhami.
Pneumococcal vaccine for asthma.
Cochrane Database of Systematic Reviews, 1 (2002),
[89.]
P.G. Gibson, J. Coughlan, A.J. Wilson, M. Abramson, A. Bauman, M.J. Hensley, et al.
Self-management education and regular practitioner review for adults with asthma.
Cochrane Database Syst Rev, 62 (2000),
[90.]
J.P. Guevara, F.M. Wolf, C.M. Grum, N.M. Clark.
Effects of educational interventions for self management of asthma in children and adolescents: systematic review and meta-analysis.
BMJ, 326 (2003), pp. 1308-1319
[91.]
S.L. Janson, J.V. Fahy, J.K. Covington, S.M. Paul, W.M. Gold, H.A. Boushey.
Effects of individual self management education on clinical, biological, and adherence outcomes in asthma.
Am J Med, 115 (2003), pp. 620-626
[92.]
N.M. Clark, F. Nothwehr, M. Gong, D. Evans, L.A. Maiman, M.E. Hurwitz, et al.
Physician-patient partnership in managing chronic illness.
Acad Med, 70 (1995), pp. 957-960
[93.]
K.R. Chapman, L. Walker, S. Cluley, L. Fabbri.
Improving patient compliance with asthma therapy.
Respir Med, 94 (2000), pp. 2-9
[94.]
R.J. Adams, K. Boath, S. Homan, D.A. Campbell, R.E. Ruffin.
A randomized trial of peak-flow and symptom-based action plans in adults with moderate-to-severe asthma.
Respirology, 6 (2001), pp. 297-304
[95.]
R. Horne.
Compliance, adherence, and concordance: implications for asthma treatment.
Chest, 130 (2006), pp. S65-S72
[96.]
J. Douglass, R. Aaroni, D. Goeman, K. Stewart, S. Sawyer, F. Thien, et al.
A qualitative study of action plans for asthma.
BMJ, 324 (2002), pp. 1003-1005
[97.]
W.N. Hopman, N. Garvey, J. Olajos-Clow, A. White-Markham, M.D. Lougheed.
Outcomes of asthma education: results of a multisite evaluation.
Can Respir J, 11 (2004), pp. 291-297
[98.]
A. Lahdensuo.
Guided self management of asthma – How to do it.
BMJ, 319 (1999), pp. 759-760
[99.]
M.R. Partridge, S.R. Hill.
Enhancing care for people with asthma: the role of communication, education, training and self-management. 1998 World Asthma Meeting Education and Delivery of Care Working Group.
Eur Respir J, 16 (2000), pp. 333-348
[100.]
M.J. Abramson, M.J. Bailey, F.J. Couper, J.S. Driver, O.H. Drummer, A.B. Forbes, et al.
Are asthma medications and management related to deaths from asthma?.
Am J Respir Crit Care Med, 163 (2001), pp. 12-18
[101.]
J.R. Smith, M. Mugford, R. Holland, B. Candy, M.J. Noble, B.D. Harrison, et al.
A systematic review to examine the impact of psycho-educational interventions on health outcomes and costs in adults and children with difficult asthma.
Health Technol Assess, 9 (2005), pp. 1-182
[102.]
P.G. Gibson, H. Powell.
Written action plans for asthma: an evidence-based review of the key components.
Thorax, 59 (2004), pp. 94-99
[103.]
A.T. Ten Brinke, P.J. Sterk, A.A.M. Masclee, P. Spinhoven, J.T. Schimdt, A.H. Zwinderman, et al.
Risk factors of frequent exacerbations in difficult-to-treat asthma.
Eur Respir J, 26 (2005), pp. 812-818
[104.]
J. Serrano, V. Plaza, B. Sureda, J. De Pablo, C. Picado, S. Bardagi, et al.
Alexithymia: a relevant psychological variable in near-fatal asthma.
Eur Respir J, 28 (2006), pp. 296-302
[105.]
J. Côté, D.M. Bowie, P. Robichaud, J.G. Parent, L. Battisti, L.P. Boulet.
Evaluation of two different educational interventions for adult patients consulting with acute asthma exacerbation.
Am J Respir Crit Care Med, 63 (2001), pp. 1415-1419
[106.]
S.D. Edmond, C.R. Reed, L.G. Graff, S. Clark, C.A. Camargo.
Asthma education in the emergency department.
Ann Emerg Med, 36 (2000), pp. 2004-2011
[107.]
L.M. Osman, C. Calder, D.J. Godden, J.A. Friend, L. McKenzie, J.S. Legge, et al.
A randomised trial of self-management planning for adult patients admitted to hospital with acute asthma.
Thorax, 57 (2002), pp. 869-874
[108.]
C.L. Emerman, R. Cydulka.
Effect of pulmonary function test on the management of acute asthma.
Arch Intern Med, 155 (1995), pp. 2225-2228
[109.]
I. Dahlén, C. Janson.
Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease.
Chest, 122 (2002), pp. 1633-1637
[110.]
G.J. Rodrigo, C. Rodrigo, L.J. Nannini.
Asma fatal o casi fatal: ¿entidad clínica o manejo inadecuado?.
Arch Bronconeumol, 40 (2004), pp. 24-33
[111.]
W.O. Spitzer, S. Suissa, P. Ernst, R.I. Horwitz, B. Habbick, D. Cockcroft, et al.
The use of beta-agonist and the risk of death and near death from asthma.
N Engl J Med, 326 (1992), pp. 501-506
[112.]
P.M. Sturdy, C.R. Victor, H.R. Anderson, J.M. Bland, B.K. Butland, B.D. Harrison, et al.
Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study.
Thorax, 57 (2002), pp. 1034-1039
[113.]
C.C. Teerlink, M.J. Hegewald, L.A. Cannon-Albright.
A genealogical assessment of heritable predisposition to asthma mortality.
Am J Respir Crit Care Med, 176 (2007), pp. 865-870
[114.]
E.R. McFadden, R. Kisser, W.J. De Groot.
Acute bronchial asthma: relations between clinical and physiological manifestations.
N Engl J Med, 288 (1973), pp. 221-225
[115.]
R.M. Nowak, M.I. Pensier, D.D. Sarkar, J.A. Anderson, P.A. Kvale, A.E. Ortiz, et al.
Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma.
Ann Emerg Med, 11 (1982), pp. 64-69
[116.]
G. Rodrigo, C. Rodrigo.
Assessment of the patient with acute asthma in the emergency department. A factor analytic study.
Chest, 104 (1993), pp. 1325-1328
[117.]
R.A. Silverman, E. Flaster, P.L. Enright, S.G. Simonson.
FEV1 performance among patients with acute asthma. Results from a multicenter clinical trial.
Chest, 131 (2007), pp. 164-171
[118.]
M.G. Pearson, D.P. Spence, I. Ryland, B.D. Harrison.
Value of pulsus paradoxus in assessing acute severe asthma. British Thoracic Society Standards of Care Committee.
BMJ, 307 (1993), pp. 659
[119.]
G.D. Jay, K. Onuma, R. Davis, M.H. Chen, A. Mansell, D. Steele.
Analysis of physician ability in the measurement of pulsus paradoxus by sphygmomanometry.
Chest, 118 (2000), pp. 348-352
[120.]
M. Gill, S. Walker, A. Khan, S.M. Green, L. Kim, S. Gray, et al.
Exhaled nitric oxide levels during acute asthma exacerbation.
Acad Emerg Med, 12 (2005), pp. 579-586
[121.]
G. Rodrigo, C. Rodrigo.
A new index for early prediction of hospitalization in. patients with acute asthma.
Am J Emerg Med, 15 (1997), pp. 8-13
[122.]
C. Rodrigo, G. Rodrigo.
Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma.
Chest, 113 (1998), pp. 593-598
[123.]
G. Rodrigo, C. Rodrigo.
Early prediction of poor response in acute asthma patients in the emergency department.
Chest, 114 (1998), pp. 1016-1021
[124.]
M. McCarren, R.J. Zalenski, M. McDermott, K. Kaur.
Predicting recovery from acute asthma in an emergency diagnostic and treatment unit.
Acad Emerg Med, 7 (2000), pp. 28-35
[125.]
R.Y. Lin, D. Sauter, T. Newman, J. Sirleaf, J. Walters, M. Tavakol.
Continuous versus intermittent albuterol nebulization in the treatment of acute asthma.
Ann Emerg Med, 22 (1993), pp. 1847-1853
[126.]
G.S. Rudnitsky, R.S. Eberlein, J.M. Schoffstall, J.E. Mazur, W.H. Spivey.
Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department.
Ann Emerg Med, 22 (1993), pp. 1842-1846
[127.]
C. Reisner, A. Kotch, G. Dworkin.
Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study.
Ann Allergy Asthma Immunol, 75 (1995), pp. 41-47
[128.]
M.B. Dolovich, R.C. Ahrens, D.R. Hess, P. Anderson, R. Dhand, J.L. Rau, et al.
Device selection and outcomes of aerosol therapy: evidence-based guidelines.
Chest, 127 (2005), pp. 335-371
[129.]
C.J. Cates, J.A. Crilly, B.H. Rowe.
Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.
Cochrane Database of Systematic Reviews, 2 (2006),
[130.]
B.H. Rowe, C. Spooner, F.M. Ducharme, J.A. Bretzlaff, G.W. Bota.
Early emergency department treatment of acute asthma with systemic corticosteroids.
Cochrane Database of Systematic Reviews, (2001),
[131.]
J. Kolbe, W. Fergusson, J. Garret.
Rapid onset asthma: a severe but uncommon manifestation.
Thorax, 53 (1998), pp. 241-247
[132.]
J.W. Chien, R. Ciufo, R. Novak, M. Skowronski, J. Nelson, A. Coreno, et al.
Uncontrolled oxygen administration and respiratory failure in acute asthma.
Chest, 117 (2000), pp. 728-733
[133.]
G.J. Rodrigo, M. Rodríguez-Verde, V. Peregalli, C. Rodrigo.
Effects of short-term 28% and 100% oxygen in PaCO2 and peak expiratory flow rate in acute asthma. A randomized trial.
Chest, 124 (2003), pp. 1312-1317
[134.]
L. Strauss, R. Hejal, G. Galan, L. Dixon, E.R. McFadden.
Observations of the effects of aerosolized albuterol in acute asthma.
Am J Respir Crit Care Med, 155 (1997), pp. 545-548
[135.]
A. Travers, A.P. Jones, K. Kelly, S.J. Barker, C.A. Camargo, B.H. Rowe.
Intravenous beta2-agonists for acute asthma in the emergency department.
Cochrane Database of Systematic Reviews, 1 (2001),
[136.]
K.B. Newman, S. Milne, C. Hamilton, K. Hall.
A comparison of albuterol administered by metered-dose inhaler and spacer with albuterol by nebulizer in adults presenting to an urban emergency department with acute asthma.
Chest, 121 (2002), pp. 1036-1041
[137.]
M.H. Osmond, M. Gazarian, R.L. Henry, T.J. Clifford.
Barriers to metered-dose inhaler/spacer use in Canadian pediatric emergency departments: a national survey.
Acad Emerg Med, 14 (2007), pp. 1106-1113
[138.]
K.F. Hurley, J. Sargeant, J. Duffy, I. Sketris, D. Sinclair, J. Ducharme.
Perceptual reasons for resistance to change in the emergency department use of holding chambers for children with asthma.
Ann Emerg Med, 51 (2008), pp. 70-77
[139.]
G.J. Rodrigo, C. Rodrigo.
Continuous vs. intermittent beta-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis.
Chest, 122 (2002), pp. 160-165
[140.]
Camargo CA, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists for acute asthma. Cochrane Database of Systematic Reviews. 2003b;4:CD001115. DOI: 10.1002/14651858.CD001115.
[141.]
G.J. Rodrigo, H. Neffen, F.D. Colodenco, J.A. Castro-Rodriguez.
Formoterol for acute asthma in the emergency department: A systematic review with meta-analysis.
Ann Allergy Asthma Immunol, 104 (2010), pp. 247-252
[142.]
R. Nowak, C.H. Emerman, J.P. Hanrahanc, M.V. Parsey, N.A. Hanania, R. Claus, et al.
A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
Am J Emerg Med, 24 (2006), pp. 259-267
[143.]
G.J. Rodrigo, L.J. Nannini.
Comparison between nebulized adrenaline and beta2 agonists for the treatment of acute asthma. A meta-analysis of randomized trials.
Am J Emerg Med, 24 (2006), pp. 217-222
[144.]
G.J. Rodrigo, J.A. Castro-Rodríguez.
Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis.
Thorax, 60 (2005), pp. 740-746
[145.]
G. Rodrigo, C. Rodrigo.
Corticosteroids in the Emergency Department therapy of acute adult asthma. An evidence-based evaluation.
Chest, 116 (1999), pp. 285-295
[146.]
B.H. Rowe, C.H. Spooner, F.M. Ducharme, G.W. Bota.
Corticosteroids for preventing relapse following acute exacerbations of asthma.
Cochrane Database of Systematic Reviews, 3 (2007),
[147.]
F.A. Lederle, R.E. Pluhar, A.M. Joseph, D.E. Niewoehner.
Tapering of corticosteroid therapy following exacerbation of asthma. A randomized, double-blind, placebo-controlled trial.
Arch Intern Med, 147 (1987), pp. 2201-2203
[148.]
B.R. O’Driscoll, S. Kalra, C.A.C. Pickering, K.B. Carroll, A.A. Woodcock, M. Wilson.
Double-blind trial of steroid tapering in acute asthma.
Lancet, 341 (1993), pp. 324-327
[149.]
M.Q. Hatton, A.S. Vathenen, M.J. Allen, S. Davies, N.J. Cooke.
A comparison of “abruptly stopping” with “tailing off” oral corticosteroids in acute asthma.
Respir Med, 89 (1995), pp. 101-104
[150.]
G.J. Rodrigo.
Rapid effects of inhaled corticosteroids in acute asthma. An evidence-based evaluation.
Chest, 130 (2006), pp. 1301-1311
[151.]
B.H. Rowe, J.A. Bretzlaff, C. Bourdon, G.W. Bota, C.A. Camargo.
Magnesium sulfate for treating exacerbations of acute asthma in the emergency department.
Cochrane Database of Systematic Reviews, 1 (2000),
[152.]
R.A. Silverman, H. Osborn, J. Runge, E.J. Gallagher, W. Chiang, J. Feldman, et al.
IV magnesium sulfate in the treatment of acute severe asthma. A multicenter randomized controlled trial.
Chest, 122 (2002), pp. 489-497
[153.]
M. Blitz, S. Blitz, R. Beasely, B.M. Diner, R. Hughes, J.A. Knopp, et al.
Inhaled magnesium sulphate in the treatment of acute asthma.
Cochrane Database of Systematic Reviews, 4 (2005),
[154.]
G.J. Rodrigo, L.J. Nannini.
Is there a place for nebulized magnesium sulfate in the treatment of acute asthma? A systematic review.
Curr Ther, 1 (2006), pp. 181-185
[155.]
K. Parameswaran, J. Belda, B.H. Rowe.
Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma.
Cochrane Database of Systematic Reviews, 4 (2000),
[156.]
G. Rodrigo, C. Pollack, C. Rodrigo, B.H. Rowe.
Heliox for nonintubated acute asthma patients.
Cochrane Database of Systematic Reviews, 4 (2006), pp. CD002884
[157.]
C.A. Camargo, H.A. Smithline, M.O. Malice, S.A. Green, T.F. Reiss.
Randomized controlled trial of intravenous montelukast in acute asthma.
Am J Respir Crit Care Med, 167 (2003), pp. 528-533
[158.]
A.C. Cylly, A. Kara, T. Ozdemir, C. Ogus, K.H. Gulkesen.
Effects of oral montelukast on airway function in acute asthma.
Respir Med, 97 (2003), pp. 533-536
[159.]
S.L. Johnston, F. Blasi, P.N. Black, R.J. Martin, D.J. Farrel, R.B. Nieman.
The effect of telithromycin in acute exacerbations of asthma.
N Engl J Med, 354 (2006), pp. 1589-1600
[160.]
K.S. Joseph, L. Blais, P. Ernst, S. Suissa.
Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers.
BMJ, 312 (1996), pp. 79-82
[161.]
A. Soroksky, D. Stav, I. Shpirer.
A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack.
Chest, 123 (2003), pp. 1018-1025
[162.]
A. Grunfeld, J.M. Fitzgerald.
Discharge considerations in acute asthma.
Can Respir J, 3 (1996), pp. 322-324
[163.]
R. Darioli, C. Perret.
Mechanical controlled hypoventilation in status asthmaticus.
Am Rev Respir Dis, 129 (1984), pp. 385-387
[164.]
D.V. Tuxen.
Permissive hypercapnic ventilation.
Am J Respir Crit Care Med, 150 (1994), pp. 870-874
[165.]
J.A. Castro-Rodríguez, C.J. Holberg, A.L. Wright, F.D. Martínez.
A clinical index to define risk of asthma in young children with recurrent wheezing.
Am J Respir Crit Care Med, 162 (2000), pp. 1403-1406
[166.]
S.V. Mehta, P.C. Parkin, D. Stephens, K.A. Keogh, S. Schuh.
Oxygen saturation as a predictor of prolonged, frequent bronchodilator therapy in children with acute asthma.
J Pediatr, 145 (2004), pp. 641-645
[167.]
K.A. Keogh, C. Macarthur, P.C. Parkin, D. Stephens, R. Arseneault, O. Tennis, et al.
Predictors of hospitalization in children with acute asthma.
J Pediatr, 139 (2001), pp. 273-277
[168.]
D. Pavón, J.A. Castro-Rodríguez, L. Rubilar, G. Girardi.
Relation between pulse oximetry and clinical score in children with acute wheezing less than 24 months of age.
Pediatr Pulmonol, 27 (1999), pp. 423-427
[169.]
J.A. Castro-Rodríguez, G.J. Rodrigo.
Beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis.
J Pediatr, 145 (2004), pp. 172-177
[170.]
J.C. Carl, T.R. Myers, H.L. Kirchner, C.M. Kercsmar.
Comparison of racemic albuterol and levalbuterol for treatment of acute asthma.
J Pediatr, 143 (2003), pp. 731-736
[171.]
R.J. Scarfone, S.M. Fuchs, A.L. Nager, S.A. Shane.
Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma.
Pediatrics, 92 (1993), pp. 513-583
[172.]
D.M. Gries, D.R. Moffitt, E. Pulos, E.R. Carter.
A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children.
J Pediatr, 136 (2000), pp. 298-303
[173.]
A. Mitra, D. Bassler, K. Watts, T.J. Lasserson, F.M. Ducharme.
Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators.
Cochrane Database of Systematic Reviews, 2 (2005),
[174.]
S.R. Smith, B.H. Baty, D. Hodge.
Validation of the pulmonary score. An asthma severity score for children.
Acad Emerg Med, 9 (2002), pp. 99-104
[175.]
M.S. Rhanana, R.P. Geilen, S. Singui, M. Van der Akker, N.H. Chavannes.
Which clinical signs and symptoms predict hypoxemia in acute childhood asthma?.
Indian J Pediatr, 73 (2006), pp. 771-775
[176.]
W. Carroll, W. Lenney.
Drug therapy in the management of acute asthma.
Arch Dis Child Educ Pract Ed, 92 (2007), pp. 82-86
[177.]
F. Qureshi, A. Zaritsky, C. Welch, T. Meadows, B.L. Burke.
Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma.
Ann Emerg Med, 46 (2005), pp. 29-36
[178.]
M.E. Ralston, M.S. Euwema, K.R. Knecht.
Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial.
J Emerg Med, 29 (2005), pp. 29-35
[179.]
J.M. Becker, A. Aroraq, R.J. Scarfone, N.D. Spector, M.E. Fontana-Penn, E. Gracely.
Oral versus intravenous corticosteroids in children hospitalized with asthma.
J Allergy Clin Immunol, 103 (1999), pp. 586-590
[180.]
T.A. Bradshaw, S.P. Matusiewicz, G.K. Crompton, J.A. Innes, A.P. Greening.
Intravenous magnesium sulphate provides no additive benefit to standard management in acute asthma.
Respir Med, 102 (2008), pp. 143-149
[181.]
J.J. Zorc, R.J. Scarfone, Y. Li, T. Hong, M. Harmelin, L. Grunstein.
Scheduled follow-up after a pediatric emergency department visit for asthma: a randomized trial.
Pediatrics, 111 (2003), pp. 495-502
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica
Idiomas
Archivos de Bronconeumología

Suscríbase a la newsletter

Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.